Tag: TIGERTRIEVER 13
Rapid completes enrolment in DISTALS trial evaluating Tigertriever 13 device for...
Rapid Medical has announced the completion of patient enrolment in the DISTALS trial—a multicentre randomised study assessing the Tigertriever 13 device in patients with distal/medium-vessel occlusions...
Rapid completes interim safety analysis of DISTALS study evaluating Tigertriever 13...
Rapid Medical has announced completion of the interim safety analysis from the multicentre, pivotal DISTALS study, reporting no safety concerns in medium vessel occlusions...
Rapid Medical gains US FDA clearance for “smallest and only” adjustable...
Rapid Medical announced at the ongoing Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) that it has recently received US...
